Table 1.
Parameter | Study 326 [10] |
Asian subanalysis [23] |
||
---|---|---|---|---|
Donepezil 23 mg/day (n = 963) | Donepezil 10 mg/day (n = 471) | Donepezil 23 mg/day (n = 145) | Donepezil 10 mg/day (n = 78) | |
Patients with at least 1 TEAE | 73.7 | 63.7 | 82.1 | 71.8 |
TEAEs | ||||
Nausea | 11.8 | 3.4 | 15.9 | 6.4 |
Vomiting | 9.2 | 2.5 | 15.2 | 3.8 |
Diarrhea | 8.3 | 5.3 | 6.9 | 3.8 |
Anorexia | 5.3 | 1.7 | 10.3 | 2.6 |
Dizziness | 4.9 | 3.4 | 8.3 | 6.4 |
Weight decrease | 4.7 | 2.5 | 5.5 | 3.8 |
Headache | 4.3 | 3.2 | 6.9 | 3.8 |
Patients who discontinued due to TEAEs | 18.6 | 7.9 | 21.4 | 10.3 |
Most common TEAEs leading to discontinuation | ||||
Vomiting | 2.9 | 0.4 | 4.1 | 1.3 |
Nausea | 1.9 | 0.4 | 2.1 | 0 |
Values are percentages.